About Riata Life Sciences Private Limited
Data last updated:
Riata Life Sciences Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Synergia Life Sciences Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 January 2013.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U15100MH2013PTC402612. Its GSTIN is 24AAGCR2236J1ZG (Gujarat).
The company had an authorised share capital of ₹37.75 Cr and a paid-up capital of ₹36.85 Cr. It was formerly known as Riata Organics Private Limited. It was led by directors including Manish Kumar Mittal and Krishnamohan Puvvada.
Its last annual general meeting (AGM) was held on 12 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹16.11 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net loss of ₹4.78 Cr (net margin -29.7%) and EBITDA of ₹4.08 Cr (EBITDA margin 25.3%).
The company had about 24 employees on its provident fund (EPFO) records before it was dissolved.
As per MCA filings, the company had open charges of ₹50 Lakh and satisfied charges of ₹11 Cr on record. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹1.65 Cr; the latest was in March 2016. The company has 7 MSME Form 1 returns on record between 2021 and 2023, listing 218 overdue payments to 50 micro and small suppliers.
The last known website on record is novozymes.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUnit No 1503 15th Floor Universal Majestic, Pl Lokhande Marg Ghatkopar Mankhurd Link Road Govandi, Mumbai, Maharashtra, India – 400043
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Riata Life Sciences Private Limited FY 2024 filings available
Riata Life Sciences Private Limited reported revenue of ₹16.11 Cr (up 21% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Riata Life Sciences Private Limited
Revenue rose 21% in the latest year. EBITDA rose 408% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Riata Life Sciences Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹16.11 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.08 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.78 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Riata Life Sciences Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -29.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Riata Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Riata Life Sciences Private Limited
Riata Life Sciences Private Limited is audited by B S R & Co. LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B S R & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Riata Life Sciences Private Limited
Riata Life Sciences has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar Mittal | Director | 09 Dec 2021 | 4 Years 10 Months | As last reported |
| Krishnamohan Puvvada | Director | 09 Dec 2021 | 4 Years 10 Months | As last reported |
| Sanjay Ajabrao Soor Also directs: Synergia Life Sciences Private Limited | Director | 09 Dec 2021 | 4 Years 10 Months | As last reported |
Ownership and Shareholding of Riata Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Riata Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2013 | Bank of Baroda | ₹5.5 Cr | Satisfied |
| 10 Apr 2013 | Bank of Baroda | ₹5.5 Cr | Satisfied |
Total charge records: 2 View all charges
Deals & Funding of Riata Life Sciences Private Limited
Riata Life Sciences Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹1.65 Cr; the latest was in March 2016.
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Synergia Life Sciences Private Limited, an individual Seller: Viridis Biopharma Private Limited , 2 individuals |
| Dec 2013 | Secondary share transfer | Undisclosed | Buyer: Viridis Biopharma Private Limited Seller: an individual |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Riata Life Sciences Private Limited
Riata Life Sciences Private Limited has 7 MSME Form 1 returns on record between 2021 and 2023, listing 218 overdue payments to 50 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 50)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 7 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Riata Life Sciences Private Limited
Riata Life Sciences Private Limited has a workforce of 24 employees as of Apr 02, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Riata Life Sciences Private Limited
Riata Life Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U15100MH2013PTC402612, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U15100MH2013PTC402612 | Current |
| U24100GJ2013PTC073250 | Previous |
| U15100GJ2013PTC073250 | Previous |
Recent Activity on Riata Life Sciences Private Limited
Riata Life Sciences Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Biren Patel ceased to be Director on 03 Jan 2023.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Riata Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Riata Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Riata Life Sciences Private Limited
Riata Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCR2236J1ZG | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Riata Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Riata Life Sciences Private Limited
Riata Life Sciences has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Riata Life Sciences was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 03 January 2013 and is registered under CIN U15100MH2013PTC402612. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Riata Life Sciences was incorporated on 03 January 2013. It is registered with the Registrar of Companies, Mumbai.
Riata Life Sciences had 3 directors:
- Manish Kumar Mittal - Director
- Krishnamohan Puvvada - Director
- Sanjay Ajabrao Soor - Director
The CIN (Corporate Identification Number) of Riata Life Sciences is U15100MH2013PTC402612. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Riata Life Sciences is at Unit No 1503 15th Floor Universal Majestic, Pl Lokhande Marg Ghatkopar Mankhurd Link Road Govandi, Mumbai, Maharashtra, India – 400043.
Riata Life Sciences can be reached through the website novozymes.com. Its registered office is in Mumbai, Maharashtra, India.
Riata Life Sciences reported revenue of ₹16.11 Cr for FY 2023 (up 21% YoY).
Riata Life Sciences has an authorised share capital of ₹37.75 Cr and a paid-up capital of ₹36.85 Cr.
Riata Life Sciences reported a net loss of ₹4.78 Cr (net margin -29.7%) and EBITDA of ₹4.08 Cr (EBITDA margin 25.3%) for FY 2023, as per its filed financial statements.
The GSTIN of Riata Life Sciences is 24AAGCR2236J1ZG, registered in Gujarat.